- Home
- DALN vs PDSB Comparison
DALN vs PDSB Comparison
Compare DALN & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DALN
- PDSB
- Stock Information
- Founded
- DALN 1954
- PDSB 2005
- Country
- DALN United States
- PDSB United States
- Employees
- DALN N/A
- PDSB N/A
- Industry
- DALN Newspapers/Magazines
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- DALN Consumer Discretionary
- PDSB Health Care
- Exchange
- DALN Nasdaq
- PDSB Nasdaq
- Market Cap
- DALN 38.1M
- PDSB 43.1M
- IPO Year
- DALN 2008
- PDSB N/A
- Fundamental
- Price
- DALN $4.36
- PDSB $1.20
- Analyst Decision
- DALN
- PDSB Strong Buy
- Analyst Count
- DALN 0
- PDSB 3
- Target Price
- DALN N/A
- PDSB $10.00
- AVG Volume (30 Days)
- DALN 24.5K
- PDSB 204.6K
- Earning Date
- DALN 04-30-2025
- PDSB 05-14-2025
- Dividend Yield
- DALN N/A
- PDSB N/A
- EPS Growth
- DALN N/A
- PDSB N/A
- EPS
- DALN 5.56
- PDSB N/A
- Revenue
- DALN $123,414,000.00
- PDSB N/A
- Revenue This Year
- DALN N/A
- PDSB N/A
- Revenue Next Year
- DALN N/A
- PDSB N/A
- P/E Ratio
- DALN $0.78
- PDSB N/A
- Revenue Growth
- DALN N/A
- PDSB N/A
- 52 Week Low
- DALN $2.98
- PDSB $0.85
- 52 Week High
- DALN $7.86
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- DALN 42.22
- PDSB 48.97
- Support Level
- DALN $4.25
- PDSB $1.20
- Resistance Level
- DALN $4.62
- PDSB $1.27
- Average True Range (ATR)
- DALN 0.32
- PDSB 0.10
- MACD
- DALN 0.00
- PDSB -0.00
- Stochastic Oscillator
- DALN 7.46
- PDSB 39.27
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.